WhatsApp

Journal of Oncology Research and Therapy

Gavin Publishers
pubmed
Abbreviation JONT
ISSN 2574-710X
Publication Type Peer Reviewed
Publishing Model Open Access
Impact Factor 4.327
DOI Prefix 10.29011/2574-710X
Journal Category Oncology Journals

About the Journal

Submissions open for Issue 1; Volume 9

'Journal of Oncology Research and Therapy' an esteemed open-access publication dedicated to ensure that crucial research reaches a global audience, fostering collaboration and innovation among researchers, clinicians, and healthcare professionals.

Scope:

Journal covers broad spectrum of topics in the field medical, surgical, and radiation oncology, along with clinical oncology.

Including but not limited to

Diagnostic Advances: Within the realm of diagnostic advances, "Journal of Oncology Research and Therapy" (JONT) delves into the multifaceted landscape of cancer diagnosis. We explore an array of methodologies, from the precision of biopsy and the insight of endoscopy to the intricate imaging techniques.

Therapeutic Innovations: In the realm of therapeutic innovations, JONT aims to publish the latest advancements in cancer treatment modalities. From traditional approaches such as surgery and chemotherapy to cutting-edge techniques like radiotherapy and immunotherapy, we delve into the diverse arsenal of treatments available. Moreover, we explore the transformative potential of personalized medicine, driven by genetic and molecular markers, in revolutionizing cancer care.

Palliative Care: In acknowledging the pivotal role of palliative care, Journal of Oncology Research & Therapy serves for disseminating studies focused on enhancing patient well-being and managing symptoms in advanced cancer. Recognizing the significance of quality of life, our publication is committed to spotlighting research that advances the understanding and delivery of palliative care in oncology.

Read More At Aims and Scope Page

Editorial Team:

Our esteemed editorial team comprises leading experts and researchers in the field of oncology. They bring a wealth of experience and a commitment to maintaining the highest standards of scientific integrity. The rigorous peer-review process ensures that published articles meet these standards and contribute meaningfully to the field.

Publication Frequency:

The Journal is published quarterly, with four issues released annually. This regular schedule ensures a steady flow of the latest research findings and developments in the field of oncology, allowing our readers to stay abreast of cutting-edge advancements throughout the year.

Abstracting and Indexing:

  • Each publication is assigned with Digital Object Identifier (DOI) number – Crossref.
  • Scilit
  • ResearchGate
  • Google Scholar
  • ScienceGate
  • Semantic Scholars
  • ACADEMIA
  • Dimensions AI
  • FatCat Wiki
  • Internet Archive Scholar
  • Directory of Open Access Scholarly Resources
  • CrossRef
  • Genamics - JournalSeek
  • Academic Keys
  • ResearchBib - Academic Research Index
  • Geneva Foundation for Medical Education and Research
  • International Innovative Journal Impact Factor (IIJIF)
  • Open J-Gate
  • Directory of Journals indexing
  • Scopus Impact Factor
  • NIH funded articles in the field will be assigned for PubMed inclusion

Why Choose Journal

  • High Quality Articles Published.
  • High Impact Factor Journal.
  • Indexing and Abstracting in Major Databases
  • We maintain high standard peer review publications.
  • We ensure optimum quality standard is maintained in every publication.
  • Increased visibility of the publication and provides free, unrestricted global access.
  • We provide higher readership, visibility and impact of your publications, we have dedicated marketing team to reach your work to broad audience.
  • The authors reserve the copyrights of the article and articles are published under a Creative Commons Attribution License.

Submit Your Manuscript:

We invite researchers, clinicians, and scientists to submit their original contributions to the Journal of Oncology Research and Therapy. Our platform provides a unique opportunity to share your work with the global oncology community and contribute to the collective knowledge in the fight against cancer.

Editorial Board

William CHO

Hong Kong

Neerja Vajpayee

USA

Enrique Alvarez Sotomayor

USA

Alok Mishra

USA

Larry E. Siref

USA

YuWei Chou

Taiwan

Yong Teng

USA

Ravindra Kolhe

USA

Sun K. Yi

USA

Antonio Cassio Assis Pellizzon

Brazil